Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Shyr

Showing results (331-340 of 435) with videos related to

Pageof 44
Sort By:
JTO Clinical and Research Reports|February 8, 2024
A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic TumorsKathryn E Beckermann, Christine M Bestvina, Badi El Osta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
A training-testing approach to the molecular classification of resected non-small cell lung cancerNoboru Yamagata, Yu Shyr, Kiyoshi Yanagisawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinomaRobbert J C Slebos, Yajun Yi, Kim Ely, et al.
Neurotoxicology|March 4, 2015
New tools for the quantitative assessment of prodrug delivery and neurotoxicityLynn E Samuelson, Randy L Scherer, Michael N VanSaun, et al.
Journal of the National Cancer Institute|January 1, 2016
Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune MicroenvironmentAnna E Vilgelm, C Andrew Johnson, Nripesh Prasad, et al.
Hypertension (Dallas, Tex. : 1979)|September 27, 2014
Oligoclonal CD8+ T cells play a critical role in the development of hypertensionDaniel W Trott, Salim R Thabet, Annet Kirabo, et al.
Cancer Research Communications|March 27, 2023
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent <i>IDH1-</i> and <i>IDH2</i>-mutant GliomaKristina Fanucci, Mary Jo Pilat, Derek Shyr, et al.
Circulation Research|September 28, 2022
A Single Nucleotide Polymorphism in <i>SH2B3/LNK</i> Promotes Hypertension Development and Renal DamageMatthew R Alexander, Samuel Hank, Bethany L Dale, et al.
Plos One|February 24, 2015
A cell-based systems biology assessment of human blood to monitor immune responses after influenza vaccinationKristen L Hoek, Parimal Samir, Leigh M Howard, et al.
JCO Precision Oncology|August 7, 2018
Genomic Profiling of T-Cell Neoplasms Reveals Frequent <i>JAK1</i> and <i>JAK3</i> Mutations With Clonal Evasion From Targeted TherapiesAllison Greenplate, Kai Wang, Rati M Tripathi, et al.
Pageof 44

Showing results (331-340 of 435) with videos related to

Sort By:
Pageof 44
JTO Clinical and Research Reports|February 8, 2024
A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic TumorsKathryn E Beckermann, Christine M Bestvina, Badi El Osta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2003
A training-testing approach to the molecular classification of resected non-small cell lung cancerNoboru Yamagata, Yu Shyr, Kiyoshi Yanagisawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinomaRobbert J C Slebos, Yajun Yi, Kim Ely, et al.
Neurotoxicology|March 4, 2015
New tools for the quantitative assessment of prodrug delivery and neurotoxicityLynn E Samuelson, Randy L Scherer, Michael N VanSaun, et al.
Journal of the National Cancer Institute|January 1, 2016
Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune MicroenvironmentAnna E Vilgelm, C Andrew Johnson, Nripesh Prasad, et al.
Hypertension (Dallas, Tex. : 1979)|September 27, 2014
Oligoclonal CD8+ T cells play a critical role in the development of hypertensionDaniel W Trott, Salim R Thabet, Annet Kirabo, et al.
Cancer Research Communications|March 27, 2023
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent <i>IDH1-</i> and <i>IDH2</i>-mutant GliomaKristina Fanucci, Mary Jo Pilat, Derek Shyr, et al.
Circulation Research|September 28, 2022
A Single Nucleotide Polymorphism in <i>SH2B3/LNK</i> Promotes Hypertension Development and Renal DamageMatthew R Alexander, Samuel Hank, Bethany L Dale, et al.
Plos One|February 24, 2015
A cell-based systems biology assessment of human blood to monitor immune responses after influenza vaccinationKristen L Hoek, Parimal Samir, Leigh M Howard, et al.
JCO Precision Oncology|August 7, 2018
Genomic Profiling of T-Cell Neoplasms Reveals Frequent <i>JAK1</i> and <i>JAK3</i> Mutations With Clonal Evasion From Targeted TherapiesAllison Greenplate, Kai Wang, Rati M Tripathi, et al.
Pageof 44